Y-mabs Therapeutics, Inc.
YMAB
Revenue
26.50M
▲8.03M▲43.52%
3 Months ChangeAssets
119.90M
▼-1.01M▼-0.8378%
3 Months ChangeLiabilities
27.90M
▼-588.00k▼-2.06%
3 Months ChangeFree Cash Flow
-32.26M
▼-10.48M▼-48.11%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-20
Form 8-K
ID: 0001558370-24-012925
2024-09-17
Form 8-K
ID: 0001558370-24-012850
2024-08-12
Form 10-Q
ID: 0001558370-24-011795
2024-08-12
Form 8-K
ID: 0001558370-24-011792
2024-07-19
Form 8-K
ID: 0001558370-24-009915
2024-07-01
Form 8-K
ID: 0001558370-24-009643
2024-06-28
Form 8-K
ID: 0001558370-24-009614
2024-06-13
Form 8-K
ID: 0001104659-24-071250
2024-05-07
Form 10-Q
ID: 0001558370-24-007056
2024-05-07
Form 8-K
ID: 0001558370-24-007047